Frontiers in Cardiovascular Medicine (Oct 2022)
Substantially different findings concerning the cardiovascular and cerebrovascular effectiveness of GLP1RAs vs. SGLT2is
Abstract
No abstracts available.Keywords
Frontiers in Cardiovascular Medicine (Oct 2022)